Live feed08:05:00·142dPRReleaseBioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic CommercializationBGLC· BioNexus Gene Lab CorpHealth CareOriginal source
